Attached files

file filename
10-K - APPLIED ENERGETICS, INC.v177422_10k.htm
EX-23 - APPLIED ENERGETICS, INC.v177422_ex23.htm
EX-99.3 - APPLIED ENERGETICS, INC.v177422_ex99-3.htm

EXHIBIT 99.2             
 
Nominating and Corporate Governance Committee Charter

The Board of Directors (“Board”) of Applied Energetics, Inc. (“Company” or “Applied Energetics”) is committed to establishing and maintaining corporate governance practices designed to aid the long-term success of the Company and effectively enhance and protect shareholder value.  Central to effective corporate governance at Applied Energetics is the Nominating and Corporate Governance Committee (the “Committee”). This Committee reports to the Board on corporate governance matters.

Membership

The Committee is comprised of no less than two independent members of the Board. Director independence, at a minimum, is consistent with applicable rules for Nasdaq-traded issuers.  Specific director independence guidelines are specified in the Company’s “Corporate Governance Principles.”  The Committee maintains a chair.  The chair is an independent member of the Board.  The Committee chair and members serve one year renewable terms.

Responsibilities

The Committee’s responsibilities include the following:
 
 
·
Develop and periodically review the effectiveness of the Board’s corporate governance guidelines.  The Committee makes recommendations on revisions to these guidelines as appropriate.  Included among these responsibilities is keeping the Board apprised of impending corporate governance guidelines and “best practices.”
 
 
·
Monitor and protect the Board’s independence.
 
 
·
Oversee and review the Company’s processes for providing information to the Board.
 
 
·
Recommend appropriate Board structures and membership, including the removal of directors, as necessary.
 
 
·
Recommend appropriate Board committee structures and membership including the existence of a Lead Independent Director, in accordance with the Corporate Governance Principles.  The Board has determined that there are three committees essential to effective governance.  These are the Audit, Compensation, and Nominating and Corporate Governance Committees.  The Board is committed to ensuring the independence of these committees. Committee independence is evaluated in light of the Sarbanes-Oxley Act of 2002, Nasdaq Rules and the Company’s “Corporate Governance Principles”.
 
 
·
Establish procedures for the director nomination process and recommend nominees for election or appointment to the Board.  The Committee evaluates the background and qualifications of director nominees, including those nominated by the Company’s stockholders.  To nominate a director candidate for the Committee’s consideration, please submit the candidate’s name and qualifications to the Board of Directors c/o Corporate Secretary, 3590 East Columbia Street, Tucson, Arizona 85714.

 
 

 
 
 
·
Oversee formal evaluation of the Board, all Board committees and the Company’s Lead Independent Director.  Included is formal assessment of individual directors.  All directors will be formally evaluated prior to consideration for re-nomination to the Board.
 
 
·
Recommend and review director compensation policies.
 
 
Determine whether to appoint, conduct search for, and recommend appointment of a Chief Executive Officer to fill any vacancy of such office.
 
 
·
Secure the services of external search firms or other experts, as necessary and appropriate.  These services will be compensated from the Company provided Board of Directors budget.  This budget system is designed to ensure the independence of such external advisors.
 
 
·
Promote the quality of directors through continuing education experiences.
 
 
·
The Committee shall annually review and evaluate the Committee charter.
 
Corporate Governance Principles Applicable to Directors
 
 
·
No director shall stand for re-election who has not participated in at least 80% of the combined total of Board and committee meetings (for any committee on which that member serves), unless excused from such meetings for medical purposes, during the entire term for which he or she was elected.
 
 
·
The independent directors of the Board will meet regularly in executive session (with no management directors or management present) as often as they shall determine, but at least semi-annually.  Executive sessions of the independent directors will be called and chaired by the Chairman of the Board, if he is an independent director, or by the Lead Independent Director.  These executive session discussions may include such topics as the independent directors determine.  During such executive sessions, the Board shall have direct access to the Company’s CFO, General Counsel, CTO, or such other officer of the corporation as the Board directs.
 
 
·
Any director who is also the Chair of any Board committee shall resign as committee chair at the end of the Company’s fiscal year, if such director does not participate in at least 80% of the meetings for that committee during the fiscal year, unless excused from such meetings for medical purposes.